title: Editorial comment--statins, stroke outcome, and stroke prevention: when should we start treatment?
authors.forename: Jonathan Y
authors.initials: JY
authors.lastname: Streifler
mesh_terms: D002545:Brain Ischemia / Q000175:diagnosis / Q000188:drug therapy*; D004334:Drug Administration Schedule; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D012107:Research Design; D012720:Severity of Illness Index; D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy* / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018696:Neuroprotective Agents